Managing change with OTC derivatives reforms
With OTC derivatives global regulatory reform comes sweeping changes for all financial institutions. We provide practical OTC derivatives advisory services to our clients worldwide, delivered by a cross-functional team of experienced professionals.
Our global reach
Our professionals have extensive experience serving banking clients across all phases of the OTC derivatives implementation life cycle, with both buy- and sell-side firms globally. Our knowledge spans global regulatory regimes, including Dodd-Frank and its equivalent global reform initiatives (EMIR, MiFID, OSFI, etc.).
How we make a difference
Our seasoned multi-disciplinary team is adept in client on-boarding and reporting, trade execution, clearing, collateral and margining, risk management and regulatory reporting designed to deliver insight and execution.
Read our most recent OTC derivatives thought leadership to learn more about how your business can prepare for OTC derivatives global regulatory change.
|Stay, move or stop|
How did the Dodd-Frank act change the over-the-counter (OTC) derivatives market? We discuss the new implications for derivatives defined as swaps and swap transactions.
|Survey assesses Dodd-Frank OTC derivatives readiness|
Despite the costs and uncertainty, our survey shows that business leaders are moving forward with implementation. Are you ready to comply with Dodd-Frank?.
|Manage your framework for OTC derivatives|
With reform regulators adopting rules at a steady pace, financial institutions need to understand which rules pertain to their business models and how they interact. We outline how to establish and implement a comprehensive framework to manage the complexities and of the rules and ensure your business complies with requirements.
|OTC derivatives reforms: facilitating change|
Recent global regulatory reforms have implications for the over-the-counter (OTC) derivatives markets. In this evolving environment, institutions can uncover opportunities and avoid potential risks by effectively structuring their derivatives business. Our OTC derivatives reform project approach offers guidance.
|The Dodd-Frank Act and OTC derivatives regulation|
When Congress passed the Dodd-Frank Act, financial firms and their chief compliance officers (CCOs) focused on understanding the law's provisions. Now that regulators are adopting rules at a steady pace, CCOs are shifting their priorities to ensure their business units comply with forthcoming rules. Find out which issues deserve immediate CCO attention.
|Compliance Reporter article: 'Navigating OTC Derivatives Reforms'|
This article, which appeared in Compliance Reporter's 2 May 2011 issue, discusses considerations relating to important issues that deserve CCO attention, including CCO designation, registration and clearing.